Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies DOI Open Access
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(21), P. 11669 - 11669

Published: Oct. 28, 2021

As a multifactorial disease, treatment of cancer depends on understanding unique mechanisms involved in its progression. The stem cells (CSCs) are responsible for tumor stemness and by enhancing colony formation, proliferation as well metastasis, these can also mediate resistance to therapy. Furthermore, the presence CSCs leads recurrence therefore their complete eradication have immense therapeutic benefits. present review focuses targeting natural products growth formation capacities been reported be attenuated dietary agents. These compounds induce apoptosis reduce migration invasion via EMT inhibition. A variety molecular pathways including STAT3, Wnt/β-catenin, Sonic Hedgehog, Gli1 NF-κB undergo down-regulation agents suppressing CSC features. Upon exposure agents, significant decrease occurs levels markers CD44, CD133, ALDH1, Oct4 Nanog impair stemness. suppression enhance sensitivity tumors chemotherapy radiotherapy. In addition vitro studies, experiments different preclinical models shown capacity use nanostructures improving impact is recommended rapidly translate findings clinical use.

Language: Английский

Nanoliposomes for doxorubicin delivery: Reversing drug resistance, stimuli-responsive carriers and clinical translation DOI
Mehrdad Hashemi, Fatemeh Ghadyani, Sahar Hasani

et al.

Journal of Drug Delivery Science and Technology, Journal Year: 2022, Volume and Issue: 80, P. 104112 - 104112

Published: Dec. 26, 2022

Language: Английский

Citations

28

Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint DOI
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah

et al.

Environmental Research, Journal Year: 2023, Volume and Issue: 227, P. 115683 - 115683

Published: March 17, 2023

Language: Английский

Citations

17

The pharmaco-epigenetics of hypertension: a focus on microRNA DOI Creative Commons

Serge Yaacoub,

Ammar Boudaka,

Ali Alkhatib

et al.

Molecular and Cellular Biochemistry, Journal Year: 2024, Volume and Issue: 479(12), P. 3255 - 3271

Published: Feb. 29, 2024

Hypertension is a major harbinger of cardiovascular morbidity and mortality. It predisposes to higher rates myocardial infarction, chronic kidney failure, stroke, heart failure than most other risk factors. By 2025, the prevalence hypertension projected reach 1.5 billion people. The pathophysiology this disease multifaceted, as it involves nitric oxide endothelin dysregulation, reactive oxygen species, vascular smooth muscle proliferation, vessel wall calcification, among others. With advent new biomolecular techniques, various studies have elucidated gaping hole in etiology mechanisms hypertension. Indeed, epigenetics, DNA methylation, histone modification, microRNA-mediated translational silencing appear play crucial roles altering molecular phenotype into hypertensive profile. Here, we critically review experimentally determined associations between microRNA (miRNA) molecules pharmacotherapy. Particular attention given epigenetic underlying physiological responses antihypertensive drugs like candesartan, relevant clopidogrel, aspirin, statins Furthermore, how miRNA affects pharmaco-epigenetics especially highlighted.

Language: Английский

Citations

7

The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targets DOI
Sepideh Mirzaei,

Asal Jalal Abadi,

Mohammad Gholami

et al.

European Journal of Pharmacology, Journal Year: 2021, Volume and Issue: 908, P. 174344 - 174344

Published: July 13, 2021

Language: Английский

Citations

35

Targeting Cancer Stem Cells by Dietary Agents: An Important Therapeutic Strategy against Human Malignancies DOI Open Access
Mahshid Deldar Abad Paskeh, Shafagh Asadi, Amirhossein Zabolian

et al.

International Journal of Molecular Sciences, Journal Year: 2021, Volume and Issue: 22(21), P. 11669 - 11669

Published: Oct. 28, 2021

As a multifactorial disease, treatment of cancer depends on understanding unique mechanisms involved in its progression. The stem cells (CSCs) are responsible for tumor stemness and by enhancing colony formation, proliferation as well metastasis, these can also mediate resistance to therapy. Furthermore, the presence CSCs leads recurrence therefore their complete eradication have immense therapeutic benefits. present review focuses targeting natural products growth formation capacities been reported be attenuated dietary agents. These compounds induce apoptosis reduce migration invasion via EMT inhibition. A variety molecular pathways including STAT3, Wnt/β-catenin, Sonic Hedgehog, Gli1 NF-κB undergo down-regulation agents suppressing CSC features. Upon exposure agents, significant decrease occurs levels markers CD44, CD133, ALDH1, Oct4 Nanog impair stemness. suppression enhance sensitivity tumors chemotherapy radiotherapy. In addition vitro studies, experiments different preclinical models shown capacity use nanostructures improving impact is recommended rapidly translate findings clinical use.

Language: Английский

Citations

34